Alaunos Therapeutics Inc (TCRT NASDAQ) stock market data APIs
$2.2491
-0.02(-0.9%)
as of June 16, 2026
Try our APIs with
free plan!
Alaunos Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida.
Prev. Close
2.2491
Open
2.2272
High
2.3432
Low
2.1947
52 wk Range
1.67-5.48
Market Cap
5 629 K
Shares Outstanding
2 442 K
Revenue
3 000
EPS
-0.55
Beta
-1.06
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Alaunos Therapeutics Inc data using free add-ons & libraries
Get Alaunos Therapeutics Inc Fundamental Data
Alaunos Therapeutics Inc Fundamental data includes:
- Net Revenue: 3 000
- EBITDA: -4 130 500
- Earnings Per Share: -2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Alaunos Therapeutics Inc Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2025-11-14
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Alaunos Therapeutics Inc News
New
Top Biotech Gainers: QTTB Has A Good Hair Day, GH Wins ACS Recommendation, Ebola Lifts SNGX, NNVX
(RTTNews) - Today's Top Gainers list features Q32 Bio, which announced a $55 million private placement financing; Soligenix, which is exploring the suitability of its ThermoVax platform to fight the B...
Alaunos Therapeutics completes $850,000 private placement of preferred stock
Alaunos Therapeutics, Inc. (NASDAQ:TCRT) announced that it entered into a Subscription Agreement with certain purchasers for a private placement of Series A-2 Convertible Preferred Stock. The agreemen...
Alaunos Therapeutics stock slides on $2M equity offering
* Alaunos Therapeutics (NASDAQ:TCRT [https://seekingalpha.com/symbol/TCRT]) shares fell over 14% premarket on Monday after the company launched an equity offering [https://seekingalpha.com/pr/201439...
PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading Wall Street Bank Behind Many Leading Crypto Strategies
NEWPORT BEACH, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- PMGC Capital LLC (“PMGC Capital”), a wholly owned subsidiary of PMGC Holdings Inc. (NASDAQ: ELAB), today issued a public statement urging...
Get Alaunos Therapeutics Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
